You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

patient-derived tumor-like cell clusters

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

Not yet recruiting
  • Endometrial Carcinoma Stage I
  • Atypical Endometrial Hyperplasia
  • No intervention
  • (no location specified)
Dec 3, 2022

Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Patient-derived tumor-like cell clusters (PTC) drug sensitivity testing
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 11, 2023

Recurrent High Grade Glioma Trial (Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.)

Not yet recruiting
  • Recurrent High Grade Glioma
  • Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
  • (no location specified)
Jul 21, 2022

Pathological Conditions, Signs and Symptoms Trial (patient-derived tumor-like cell clusters drug sensitivity test)

Not yet recruiting
  • Pathological Conditions, Signs and Symptoms
  • patient-derived tumor-like cell clusters drug sensitivity test
  • (no location specified)
Oct 29, 2021

Gastrointestinal Tumors Trial (PTC drug screening)

Not yet recruiting
  • Gastrointestinal Neoplasms
  • PTC drug screening
  • (no location specified)
Mar 4, 2022

HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

Recruiting
  • HER2-negative Early Breast Cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
  • Beijing, China
    Peking University People's Hospital
Mar 27, 2022

HER2-positive Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screenning)

Recruiting
  • HER2-positive Early Breast Cancer
  • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screenning
  • Beijing, Beijing, China
    Peking University People'S Hospital
Mar 28, 2021

Hyper-Personalized Medicine Using Patient Derived Xenografts for

Recruiting
  • Kidney Neoplasm
  • +2 more
    • Toronto, Ontario, Canada
      Odette Cancer Centre
    Mar 24, 2022

    Soft Tissue Sarcoma, Xenograft Model, 2D/3D Cell Cultures Trial in Amsterdam (tumor biopsy)

    Recruiting
    • Soft Tissue Sarcoma
    • +2 more
    • tumor biopsy
    • Amsterdam, Netherlands
      Netherlands Cancer Institute
    Aug 3, 2021

    Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

    Completed
    • Glioblastoma
    • +4 more
    • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
    • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Nov 18, 2021

    Patient-derived Glioma Stem Cell Organoids

    Active, not recruiting
    • Glioblastoma
    • Tumor biopsy
    • Maastricht, Limburg, Netherlands
    • +1 more
    Apr 29, 2021

    Tumor From Patients With Head and Neck Cancer

    Recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Local biopsy in the tumor
    • Brussels, Belgium
      Cliniques universitaires Saint-Luc
    Mar 18, 2021

    Colon Cancer, Rectal Cancer, Chemo Effect Trial in Beijing (5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil

    Recruiting
    • Colon Cancer
    • +4 more
    • 5-fluorouracil + formyltetrahydrofolate/Oxaliplatin + 5-fluorouracil + formyltetrahydrofolate/Irinotecan + 5-fluorouracil + formyltetrahydrofolate/Cetuximab + 5-fluorouracil + formyltetrahydrofolate
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jun 15, 2022

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Peritoneal Metastases From Colorectal Cancer Trial in Milano (Patient-tailored hyperthermic intraperitoneal chemo (HIPEC))

      Recruiting
      • Peritoneal Metastases From Colorectal Cancer
      • Patient-tailored hyperthermic intraperitoneal chemotherapy (HIPEC)
      • Milano, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori
      Sep 26, 2023

      Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)

      Not yet recruiting
      • Glioblastoma
      • 18F-GE-180 PET
      • +4 more
      • Rozzano, (mi), Italy
        IRCCS Istituto Clinico Humanitas
      Oct 27, 2023

      Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Speiser-catheter for uterine and tubal lavage)

      Completed
      • Ovarian Epithelial Cancer
      • +2 more
      • Speiser-catheter for uterine and tubal lavage
      • Graz, Austria
      • +8 more
      Sep 1, 2022

      Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection)

      Recruiting
      • Glioblastoma
      • Glioma, Malignant
      • Biological sample collection
      • Rome, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Mar 6, 2023

      Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

      Not yet recruiting
      • Refractory Tumor
      • Solid Tumor
      • Dendritic Cell Vaccine
      • +2 more
      • Kaohsiung, Taiwan
      • +2 more
      Mar 2, 2023

      ALDH1A1 Expression in Invasive Mammary Carcinoma

      Enrolling by invitation
      • Breast Cancer
        • Sohag, Egypt
          Faculty of Medicine
        Nov 12, 2023

        Ewing Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Trial in Frankfurt am Main, Freiburg, Tübingen (Peptide vaccine IPX)

        Recruiting
        • Ewing Sarcoma
        • +2 more
        • Peptide vaccine IPX
        • Frankfurt am Main, Germany
        • +2 more
        Oct 18, 2023

        Multiple Myeloma Cells From miRNAs Released From B Cells, and

        Recruiting
        • Multiple Myeloma
          • Aviano, Pordenone, Italy
            Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
          Nov 23, 2023

          Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

          Not yet recruiting
          • Advanced Sarcoma
          • NKG2D-CAR memory T cell
          • (no location specified)
          Oct 17, 2023

          Reconstitution ofHuman Immune System inPatient Derived Xenograft

          Suspended
          • Genito Urinary Cancer
          • +3 more
          • Bone marrow biopsy
          • Tumor biopsy
          • Durham, North Carolina
            Duke University Medical Center
          Nov 17, 2022

          Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

          Completed
          • Stage III Malignant Melanoma of Skin AJCC V6
          • Stage IV Malignant Melanoma of Skin
          • TAPCells vaccine
          • Santiago, RM, Chile
            Faculty of Medicine, University of Chile
          Nov 21, 2023